H.R.3 (Drug pricing bill)
The Elijah E. Cummings Lower Drug Costs Now Act, also known as the Lower Drug Costs Now Act and H.R.3, is left-wing legislation introduced and passed by House Democrats in 2019 that aims at attempting to lower drug prices merely by government regulations. Sponsored by representative Frank Pallone, Jr. (D-NJ), H.R.3 runs on the wishful thinking-based false assumptions that the pharmaceutical industry would automatically be able to comply with the regulatory demands, that government-controlled price fixing can fix problems, and that such legislation wouldn't simply reduce available drugs in the market. Unlike Republican and other bi-partisan proposals also seeking to reduce drug prices that directly address the loopholes that allow Big Pharma to get away with high prices, H.R.3 does not make a significant focus on such. In addition, unlike the much more practical bill S.3384, H.R.3 does not take trade policies into consideration as a method to reduce drug prices.
The Association of Mature American Citizens has opposed H.R.3.[1]
House Democrats childishly attempted to interrupt Donald Trump's 2020 State of the Union Address, chanting "HR 3!" to promote their legislation.[2]